[
  {
    "ts": null,
    "headline": "An Alzheimer’s startup emerges with $175M in venture backing",
    "summary": "Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics.",
    "url": "https://finnhub.io/api/news?id=7ef16e7c22a2df7fa29a55e6c2f50087eee05c05512a039485d9382885dd075f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771410174,
      "headline": "An Alzheimer’s startup emerges with $175M in venture backing",
      "id": 139137798,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics.",
      "url": "https://finnhub.io/api/news?id=7ef16e7c22a2df7fa29a55e6c2f50087eee05c05512a039485d9382885dd075f"
    }
  }
]